Detalles de la búsqueda
1.
Integrative medicine for hypermobility spectrum disorders (HSD) and Ehlers-Danlos syndromes (EDS): a feasibility study.
Disabil Rehabil;
: 1-14, 2024 Feb 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38353245
2.
Patient experience of chronic illness care and complementary integrative health use: a cross-sectional study of patients with hypermobility spectrum disorders (HSD) and Ehlers-Danlos syndromes (EDS).
Disabil Rehabil;
45(21): 3549-3559, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36222285
3.
Use of acupuncture with acupressure in addition to standard-of-care cryotherapy to decrease chemotherapy-associated neuropathy in patients with gastrointestinal malignancies receiving oxaliplatin-based chemotherapy: Study protocol for a randomized, controlled pilot and feasibility study.
Contemp Clin Trials;
131: 107273, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37380021
4.
The Acupuncture and Telehealth Survey: A Cross-Sectional Survey Exploring Early COVID-19 Impacts on the Acupuncture Profession.
J Integr Complement Med;
28(1): 36-44, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35085022
5.
Xanthohumol microbiome and signature in adults with Crohn's disease (the XMaS trial): a protocol for a phase II triple-masked, placebo-controlled clinical trial.
Trials;
23(1): 885, 2022 Oct 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-36273173
6.
Inflammatory Bowel Disease and Neutrophil-Lymphocyte Ratio: A Systematic Scoping Review.
J Clin Med;
10(18)2021 Sep 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-34575330
7.
Xanthohumol Microbiome and Signature in Healthy Adults (the XMaS Trial): Safety and Tolerability Results of a Phase I Triple-Masked, Placebo-Controlled Clinical Trial.
Mol Nutr Food Res;
65(8): e2001170, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33629812
8.
Xanthohumol microbiome and signature in healthy adults (the XMaS trial): a phase I triple-masked, placebo-controlled clinical trial.
Trials;
21(1): 835, 2020 Oct 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33028396
9.
Correction to: Xanthohumol microbiome and signature in healthy adults (the XMaS trial): a phase I triple-masked, placebo-controlled clinical trial.
Trials;
21(1): 885, 2020 Oct 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33106168
Resultados
1 -
9
de 9
1
Próxima >
>>